纵欲
发表于 2025-3-28 15:40:38
Considerations in Manufacturing Process Development for Antibody-Based Therapeutics,ntinues to grow, development of robust manufacturing processes has been a significant focus within the pharmaceutical industry. This chapter describes the work-processes, challenges, and opportunities for platform production of antibodies with a focus on production for use in human clinical trials a
围巾
发表于 2025-3-28 18:45:12
Strategies for Development of Next Generation Antibody-Based Therapeutics, growth of the biologics market. As next generation modalities confront their first-generation rivals, it is critical that next generation products present a clear differentiating advantage over the existing competition and hence offer the potential to displace their first-generation rivals based on
AGGER
发表于 2025-3-29 01:44:18
Immune Complex Therapies for Treatment of Immune Thrombocytopenia,st several years, several published reports have suggested that gamma globulin immune complexes may inhibit pathways of platelet destruction in ITP, attenuating thrombocytopenia in human patients and in animal models of ITP. This chapter reviews the literature associated with the use of immune compl
Living-Will
发表于 2025-3-29 07:09:12
http://reply.papertrans.cn/27/2700/269952/269952_44.png
最高点
发表于 2025-3-29 10:59:47
Application of Bioinformatics Principles for Target Evaluation,
SLUMP
发表于 2025-3-29 12:11:10
http://reply.papertrans.cn/27/2700/269952/269952_46.png
观察
发表于 2025-3-29 19:25:14
Im Bereiche der rhythmischen Schwankungen,, and linking PK/PD relationships to clinical outcomes. To improve prospective model predictions of drug efficacy and safety, new approaches will be needed to link antibody disposition with robust systems pharmacology models of drug and disease mechanisms.
Communal
发表于 2025-3-29 22:59:00
http://reply.papertrans.cn/27/2700/269952/269952_48.png
temperate
发表于 2025-3-30 02:31:08
http://reply.papertrans.cn/27/2700/269952/269952_49.png
Obstreperous
发表于 2025-3-30 04:09:53
Application of Pharmacokinetic/Pharmacodynamic Modeling in the Development of Antibody-Based Therap, and linking PK/PD relationships to clinical outcomes. To improve prospective model predictions of drug efficacy and safety, new approaches will be needed to link antibody disposition with robust systems pharmacology models of drug and disease mechanisms.